Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer

By Zarogoulidis K.   Papagiannis A.   Ziogas E.   Fahantidou E.   Dermitzakis G.   Gioulekas D.   Vamvalis C.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2428-2431

Elsevier

Access to resources Recommend Favorite

Oral Glutamine in the Prevention of Chemotherapy-induced Gastrointestinal Toxicity

By Muscaritoli M.   Micozzi A.   Conversano L.   Martino P.   Petti M.C.   Cartoni C.   Cascino A.   Rossi-Fanelli F.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 319-320

Elsevier

Access to resources Recommend Favorite

Prevention of chemotherapy-induced neutropenia by special honey intake

By Zidan Jamal   Shetver Lika   Gershuny Anthony   Abzah Amira   Tamam Sigalit   Stein Moshe   Friedman Eitan  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 549-552

Humana Press, Inc

Access to resources Recommend Favorite

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: A Markov model

By Borg Sixten   Glenngård Anna   Osterborg Anders   Persson Ulf  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1009-1017

Informa Healthcare

Access to resources Recommend Favorite

Protection Against Cisplatin-Induced Nephrotoxicity by Recombinant Human Erythropoietin

By Yalcin Suayib   Müftüoùglu Sevda   Cetúõn Eren   Süarer Banu   Yildirim Berna Akkusü   Zeybek Dúõlara   Orhan Bülent  

Medical Oncology, Vol. 20, Iss. 2, 2003-06 ,pp. : 169-174

Humana Press, Inc

Access to resources Recommend Favorite